News By Tag
* Stem Cells
* Stem Cell Company
* Regenerative Medicine
* Cell Therapy
* Stem-cell Research
* More Tags...
News By Location
A Visiongain report predicts the world stem cell technology market will generate $13.8bn in 2019
A new report by visiongain predicts the world stem cell technology market will generate $13.8bn in 2019, with rapid sales expansion to 2025. That forecast and others appear in Pharma Leader Series: Top Stem Cell Technology Companies 2015-2025, published in March 2015. That investigation predicts revenues and trends for the overall stem cells market and analyses prospects for the leading companies in the US, Asia-Pacific, Israel and Europe.
Visiongain is a business information publisher and consultancy in London, UK. Its new study predicts the overall stem cell market will expand rapidly from 2015 to 2025, benefiting patients, healthcare providers and biomedical companies. In 2014 cancer therapy represented the largest therapeutic application of stem cell treatments, accounting for 41.2% of the overall market. Companies also show interest in stem cells for non-therapeutic applications, such as screening in drug development. And, in 2014, the US formed the largest market for stem cells.
Arshad Ahad, a healthcare industry analyst in visiongain, said: “Stem cells have been seen for many years as an upcoming and potentially transformative technology for healthcare. In 2015 that industry is beginning to realise this huge potential. All the organisations profiled in this report have stem cell therapies in preclinical or clinical development, whilst some companies have already launched treatments on the market.
“However, that industry still has many barriers to overcome. Current reimbursement systems and regulation will need to be updated to deal with stem cell therapy on a large scale, and stem cell companies will have to attract the attention of Big Pharma, which remains wary of this exciting but controversial field. Nevertheless, stem cell therapies are on the verge of significant market expansion, and will soon start to live up to their promise.”
That new report analyses 23 leading stem cell companies in the US, Europe, Asia-Pacific and Israel. It explores their activities by:
· Analysing stem cell product portfolios and technology platforms
· Investigating the status of clinical trials, assessing progress and possibilities
· Providing forecasts for some stem cell therapies from 2015 to 2025
· Interviewing six authorities in the field, gaining their insights on that industry and its future
· Giving qualitative analyses (SWOT and STEP) of that industry and market.
Firms the survey assesses include these:
· Osiris Therapeutics
· Reliance Life Sciences
· Cardio3 BioSciences
The study also forecasts revenues to 2025 for the overall world stem cell market and five submarkets – applications for those biotechnologies.
Visiongain forecasts high revenue growth for the stem cells market from 2015. Pharma Leader Series: Top Stem Cell Technology Companies 2015-2025 analyses organisations well placed to contribute to and benefit from that commercial expansion. The new investigation adds to visiongain’s reports on industries and markets in healthcare, including biotechnology, medical devices, outsourced services and pharmaceuticals.
For sample pages and further information concerning the visiongain report Pharma Leader Series: Top Stem Cell Technology Companies 2015-2025, please visit: https://goo.gl/
For an executive summary of this report or to order it today please email:
Sara Peerun at sara.peerun@
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Aviation and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.